Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects

British Journal of Pharmacology

Volumn 133, Issue 5, 2001, Pages 722-729

  Landells, L J ^a   Szilagy, C M ^b   Jones, N A ^a   Banner, K H ^c   Allen, J M ^b   Doherty, A ^b   O'Connor, B J ^d   Spina, D ^d   Page, C P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b PFIZER INC   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Asthma; Cyclic AMP; Lymphocyte; Phosphodiesterase

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PHOSPHODIESTERASE IV; RECEPTOR SUBTYPE;

ADULT; ARTICLE; ASTHMA; BACTERIUM DETECTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; ENZYME ANALYSIS; FEMALE; HUMAN; INFLAMMATORY CELL; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECOND MESSENGER; VENOUS BLOOD;

EID: 0034944944     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704120     Document Type: Article

References (21)

1. Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis
2. Immunochemical characterization of the distinct monocyte cyclic AMP-phosphodiesterase from patients with atopic dermatitis
3. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
4. Recent progress in understanding the hormonal regulation of phosphodiesterases
5. Expression and regulation of human and rat phosphodiesterase type IV isogenes
6. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase
7. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase
8. Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A
9. Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: A comparative study
10. Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?
11. Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: Role in regulating proliferation and the biosynthesis of interleukin-2
12. Current status of cyclic nucleotide phosphodiesterase isozymes
13. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: A possible mechanism for cyclic AMP-agonist hyporesponsiveness
14. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis
15. A biochemical and functional assessment of monocyte phosphodiesterase activity in healthy and asthmatic subjects
16. CD3- and CD28-dependent induction of PDE7 required for T cell activation
17. Phosphatidic acid stimulates the rolipram-sensitive cyclic nucleotide phosphodiesterase from rat thymocytes
18. Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes
19. Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme
20. Effects of theophylline on lymphocyte phosphodiesterase activity
21. Phosphodiesterases: The journey towards therapeutics